Literature DB >> 32512287

Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.

Mohammad Ali Sahraian1, Amirreza Azimi1, Samira Navardi1, Nasim Rezaeimanesh1, Abdorreza Naser Moghadasi2.   

Abstract

Entities:  

Year:  2020        PMID： 32512287     DOI： 10.1016/j.msard.2020.102245

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN： 2211-0348            Impact factor:   4.339


× No keyword cloud information.
  8 in total

1.  The Spectrum of Neuro-COVID: A Study of a Comprehensively Investigated Large Cohort from India.

Authors:  Seena Vengalil; Rohan Mahale; N Chakradhar; Swathi Alluri; P R Sagar Navanith; V H Ganaraja; K R Haripriya; Holla Venkappayya Vikram; Ajay Asranna; Pooja Mailankody; Doniparthi V Seshagiri; H Manoj Cheerla; V N Maturu; C R Vaddepally; Raghavendra Kenchaiah; P R Srijithesh; Jaydip Ray Chaudhuri; M Netravathi; Suvarna Alladi
Journal:  Ann Indian Acad Neurol       Date:  2022-01-12       Impact factor: 1.714

2.  The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk.

Authors:  Hexiang Yin; Yao Zhang; Yan Xu; Bin Peng; Liying Cui; Shuyang Zhang
Journal:  Front Neurol       Date:  2021-03-22       Impact factor: 4.003

Review 3.  COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis.

Authors:  Mahdi Barzegar; Omid Mirmosayyeb; Narges Ebrahimi; Sara Bagherieh; Alireza Afshari-Safavi; Ali Mahdi Hosseinabadi; Vahid Shaygannejad; Nasrin Asgari
Journal:  Mult Scler Relat Disord       Date:  2021-11-01       Impact factor: 4.808

4.  The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Authors:  Sedat Sen; Asli Tuncer; Serkan Ozakbas; Cihat Uzunkopru; Cavid Baba; Serkan Demir; Yesim Beckmann; Haluk Gumus; Gokhan Arslan; Ahmet Kasim Kilic; Ayse Altintas; Nur Yuceyar; Omer Faruk Turan; Melih Tutuncu; Murat Terzi; Pinar Acar; Sena Destan Bunul; Belgin Petek Balci; Levent Sinan Bir; Mesrure Koseoglu; Semra Mungan; Tuncay Gunduz; Ipek Gungor Dogan; Dilcan Kotan; Ugur Uygunoglu; Ozgul Ekmekci; Meltem Demirkiran; Ozden Kamisli; Sibel Canbaz Kabay; Yusuf Tamam; Sami Omerhoca; Serhan Sevim; Sibel Guler; Murat Kurtuncu; Husnu Efendi; Rana Karabudak; Aksel Siva
Journal:  Mult Scler Relat Disord       Date:  2021-11-19       Impact factor: 4.339

5.  COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders.

Authors:  Vanja Jovicevic; Jovana Ivanovic; Marko Andabaka; Olivera Tamas; Nikola Veselinovic; Nikola Momcilovic; Sarlota Mesaros; Tatjana Pekmezovic; Jelena Drulovic
Journal:  Mult Scler Relat Disord       Date:  2021-10-20       Impact factor: 4.339

Review 6.  The Outcome of COVID-19 in Patients with a History of Taking Rituximab: A Narrative Review.

Authors:  Pourya Yarahmadi; Mohammad Alirezaei; Seyed Mohammad Forouzannia; Abdorreza Naser Moghadasi
Journal:  Iran J Med Sci       Date:  2021-11

7.  COVID-19 infection in NMO/SD patients: a French survey.

Authors:  Sinéad Zeidan; Elisabeth Maillart; Céline Louapre; Thomas Roux; Catherine Lubetzki; Caroline Papeix
Journal:  J Neurol       Date:  2020-09-12       Impact factor: 4.849

8.  Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus.

Authors:  Vahid Shaygannejad; Alireza Afshari-Safavi; Boshra Hatef
Journal:  Neurol Sci       Date:  2020-11-20       Impact factor: 3.830
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.